Literature DB >> 1716694

Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180.

S Reuter1, H Delius, T Kahn, B Hofmann, H zur Hausen, E Schwarz.   

Abstract

The human cervical carcinoma cell line ME180 was examined for human papillomavirus (HPV) DNA and RNA. The integrated DNA of a presumably new HPV type showing a relationship closer to HPV39 than to HPV18 was cloned and sequenced. HPV sequences from the E6-E7-E1 region are expressed as poly(A)+ RNAs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716694      PMCID: PMC249064     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames.

Authors:  K B Choo; C C Pan; S H Han
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

2.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.

Authors:  C C Baker; W C Phelps; V Lindgren; M J Braun; M A Gonda; P M Howley
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

3.  Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma.

Authors:  T Matsukura; T Kanda; A Furuno; H Yoshikawa; T Kawana; K Yoshiike
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

4.  Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.

Authors:  D Smotkin; F O Wettstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Expression of human papillomavirus types 16 and 18 DNA sequences in cervical carcinoma cell lines.

Authors:  M M Pater; A Pater
Journal:  J Med Virol       Date:  1988-10       Impact factor: 2.327

6.  Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Bauknecht; D Bartsch; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

7.  Genome organization and nucleotide sequence of human papillomavirus type 39.

Authors:  C Volpers; R E Streeck
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

8.  Nucleotide sequences of cDNAs for human papillomavirus type 18 transcripts in HeLa cells.

Authors:  Y Inagaki; Y Tsunokawa; N Takebe; H Nawa; S Nakanishi; M Terada; T Sugimura
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Oltersdorf; E Schwarz; L Gissmann
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

10.  Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.

Authors:  A Schneider-Gädicke; E Schwarz
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

View more
  18 in total

1.  General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions.

Authors:  A J van den Brule; P J Snijders; P M Raaphorst; H F Schrijnemakers; H Delius; L Gissmann; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  The 2010 global proficiency study of human papillomavirus genotyping in vaccinology.

Authors:  Carina Eklund; Ola Forslund; Keng-Ling Wallin; Tiequn Zhou; Joakim Dillner
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

3.  Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39.

Authors:  M Longuet; S Beaudenon; G Orth
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis.

Authors:  Ge Gao; Rebecca D Chernock; Hiram A Gay; Wade L Thorstad; Tian R Zhang; Hongwei Wang; Xiao-Jun Ma; Yuling Luo; James S Lewis; Xiaowei Wang
Journal:  Int J Cancer       Date:  2012-09-07       Impact factor: 7.396

5.  Intratype variation in 12 human papillomavirus types: a worldwide perspective.

Authors:  A C Stewart; A M Eriksson; M M Manos; N Muñoz; F X Bosch; J Peto; C M Wheeler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Global proficiency study of human papillomavirus genotyping.

Authors:  Carina Eklund; Tiequn Zhou; Joakim Dillner
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

7.  Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy.

Authors:  S Y Chan; H Delius; A L Halpern; H U Bernard
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Detection of multiple human papillomavirus genotypes in anal carcinoma.

Authors:  Sonia Ramamoorthy; Yu-Tsueng Liu; Linda Luo; Katsumi Miyai; Qing Lu; John M Carethers
Journal:  Infect Agent Cancer       Date:  2010-10-12       Impact factor: 2.965

9.  Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.

Authors:  Ying Zhou; Min Li; Ying Wei; Dingqing Feng; Cheng Peng; Haiyan Weng; Yang Ma; Liang Bao; Shreeram Nallar; Sudhakar Kalakonda; Weihua Xiao; Dhananjaya V Kalvakolanu; Bin Ling
Journal:  J Interferon Cytokine Res       Date:  2009-10       Impact factor: 2.607

10.  Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups.

Authors:  C K Ong; S Y Chan; M S Campo; K Fujinaga; P Mavromara-Nazos; V Labropoulou; H Pfister; S K Tay; J ter Meulen; L L Villa
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.